Teleflex (TFX) | Financial Analysis & Statements
Teleflex Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
-401.9M
Gross Profit
-151.4M
Operating Income
-164.7M
Net Income
-714.3M
Balance Sheet Metrics
Total Assets
6.9B
Total Liabilities
3.8B
Shareholders Equity
3.1B
Debt to Equity
1.22
Cash Flow Metrics
Operating Cash Flow
249.5M
Free Cash Flow
151.6M
Revenue & Profitability Trend
Annual Income Flow
2025
Teleflex Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.0B | 3.0B | 3.0B | 2.8B | 2.8B |
| Cost of Goods Sold | 872.0M | 1.3B | 1.3B | 1.3B | 1.3B |
| Gross Profit | 1.1B | 1.7B | 1.6B | 1.5B | 1.5B |
| Gross Margin % | 56.2% | 55.9% | 55.4% | 54.9% | 55.2% |
| Operating Expenses | |||||
| Research & Development | 144.8M | 161.7M | 154.4M | 153.8M | 130.8M |
| Selling, General & Administrative | 720.2M | 995.3M | 929.9M | 863.7M | 860.1M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 865.0M | 1.2B | 1.1B | 1.0B | 990.9M |
| Operating Income | 255.8M | 545.7M | 562.7M | 513.5M | 558.7M |
| Operating Margin % | 12.8% | 17.9% | 18.9% | 18.4% | 19.9% |
| Non-Operating Items | |||||
| Interest Income | 6.4M | 8.0M | 12.8M | 912.0K | 1.3M |
| Interest Expense | 100.2M | 83.5M | 85.1M | 54.3M | 57.0M |
| Other Non-Operating Income | -137.4M | -394.7M | -56.4M | -14.2M | 56.4M |
| Pre-tax Income | 24.6M | 75.5M | 434.0M | 445.9M | 559.5M |
| Income Tax | -34.0M | 5.3M | 76.4M | 83.0M | 74.3M |
| Effective Tax Rate % | -138.4% | 7.0% | 17.6% | 18.6% | 13.3% |
| Net Income | -905.6M | 69.7M | 356.3M | 363.1M | 485.4M |
| Net Margin % | -45.4% | 2.3% | 12.0% | 13.0% | 17.3% |
| Key Metrics | |||||
| EBITDA | 439.9M | 828.3M | 817.6M | 745.0M | 797.4M |
| EPS (Basic) | $-20.30 | $1.49 | $7.58 | $7.74 | $10.38 |
| EPS (Diluted) | $-20.30 | $1.48 | $7.53 | $7.68 | $10.23 |
| Basic Shares Outstanding | 44622000 | 46837000 | 46981000 | 46898000 | 46774000 |
| Diluted Shares Outstanding | 44622000 | 46837000 | 46981000 | 46898000 | 46774000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Teleflex Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 378.6M | 290.2M | 222.8M | 292.0M | 445.1M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 345.6M | 459.5M | 443.5M | 408.8M | 383.6M |
| Inventory | 404.4M | 600.1M | 626.2M | 578.5M | 477.6M |
| Other Current Assets | 150.7M | 117.9M | 107.5M | 125.1M | 117.3M |
| Total Current Assets | 1.9B | 1.5B | 1.4B | 1.4B | 1.4B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 396.2M | 400.6M | 408.1M | 403.8M | 415.0M |
| Goodwill | 6.1B | 7.5B | 8.3B | 7.4B | 7.3B |
| Intangible Assets | 1.5B | 2.3B | 2.5B | 2.3B | 2.3B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 589.6M | 114.0M | 105.7M | 95.8M | 75.9M |
| Total Non-Current Assets | 5.0B | 5.6B | 6.1B | 5.5B | 5.4B |
| Total Assets | 6.9B | 7.1B | 7.5B | 6.9B | 6.9B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 130.2M | 141.0M | 132.2M | 126.8M | 118.2M |
| Short-term Debt | 100.0M | 100.0M | 87.5M | 87.5M | 110.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 265.5M | 67.2M | 46.5M | 63.4M | 55.6M |
| Total Current Liabilities | 762.0M | 649.4M | 606.7M | 581.5M | 680.1M |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.6B | 1.7B | 1.8B | 1.7B | 1.9B |
| Deferred Tax Liabilities | 183.7M | 391.1M | 456.1M | 388.9M | 370.1M |
| Other Non-Current Liabilities | 198.1M | 104.1M | 165.9M | 159.9M | 165.4M |
| Total Non-Current Liabilities | 3.1B | 2.2B | 2.5B | 2.3B | 2.4B |
| Total Liabilities | 3.8B | 2.8B | 3.1B | 2.9B | 3.1B |
| Equity | |||||
| Common Stock | 48.2M | 48.1M | 48.0M | 48.0M | 47.9M |
| Retained Earnings | 3.1B | 4.1B | 4.1B | 3.8B | 3.5B |
| Treasury Stock | 649.5M | 350.3M | 152.1M | 154.9M | 157.3M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 3.1B | 4.3B | 4.4B | 4.0B | 3.8B |
| Key Metrics | |||||
| Total Debt | 2.7B | 1.8B | 1.9B | 1.8B | 2.0B |
| Working Capital | 1.2B | 821.8M | 800.7M | 829.5M | 749.0M |
Balance Sheet Composition
Teleflex Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -905.6M | 69.7M | 356.3M | 363.1M | 485.4M |
| Depreciation & Amortization | 177.7M | 274.6M | 242.1M | 230.6M | 237.4M |
| Stock-Based Compensation | 25.7M | 31.3M | 31.5M | 27.2M | 22.9M |
| Working Capital Changes | -9.8M | -44.8M | -100.4M | -253.4M | 155.8M |
| Operating Cash Flow | 142.5M | 214.7M | 482.3M | 333.9M | 752.0M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | -825.1M | -120.0K | -588.9M | -186.0M | 220.3M |
| Investment Purchases | -5.0M | -7.3M | -11.3M | -22.3M | -18.4M |
| Investment Sales | 0 | 7.3M | 7.3M | 7.3M | 7.3M |
| Investing Cash Flow | -738.5M | -120.0K | -592.9M | -201.0M | 209.2M |
| Financing Activities | |||||
| Share Repurchases | -300.0M | -200.0M | - | - | - |
| Dividends Paid | -60.3M | -63.5M | -63.9M | -63.8M | -63.6M |
| Debt Issuance | 1.1B | 130.0M | 646.0M | 744.2M | 400.0M |
| Debt Repayment | -153.0M | -291.5M | -544.8M | -884.5M | -1.0B |
| Financing Cash Flow | 604.4M | -425.3M | 33.4M | -213.2M | -728.3M |
| Free Cash Flow | 245.4M | 509.3M | 419.2M | 263.0M | 579.8M |
| Net Change in Cash | 8.4M | -210.7M | -77.3M | -80.3M | 232.9M |
Cash Flow Trend
Teleflex Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
104.31
Forward P/E
13.18
Price to Book
1.93
Price to Sales
3.04
PEG Ratio
0.23
Profitability Ratios
Profit Margin
-45.45%
Operating Margin
40.56%
Return on Equity
1.58%
Return on Assets
2.59%
Financial Health
Current Ratio
2.54
Debt to Equity
90.32
Beta
0.84
Per Share Data
EPS (TTM)
$1.31
Book Value per Share
$70.70
Revenue per Share
$44.66
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| TFX | 6.0B | 104.31 | 1.93 | 1.58% | -45.45% | 90.32 |
| Intuitive Surgical | 170.1B | 54.97 | 8.99 | 16.69% | 28.38% | 0.95 |
| Becton, Dickinson | 56.1B | 25.40 | 1.75 | 6.96% | 8.01% | 77.28 |
| Baxter International | 9.4B | 86.31 | 1.54 | -13.71% | -8.51% | 160.28 |
| AptarGroup | 8.0B | 21.10 | 2.99 | 15.10% | 10.40% | 57.10 |
| Repligen | 7.5B | 154.30 | 3.55 | 2.40% | 6.62% | 32.76 |
Financial data is updated regularly. All figures are in the company's reporting currency.






